Abstract
Objective and design
We present in this article 1H nuclear magnetic resonance (NMR)-based metabolic approach to screen the serum metabolic alterations in human gallbladder inflammation with chronic cholecystitis (CC).
Material/methods
Total of 71 human serum samples was divided into two groups, (n = 41, CC) and (n = 30 control). 1H NMR metabolic profiling was carried out for investigation of metabolic alterations. Multivariate statistical analysis was applied for pattern recognition and identification of metabolites playing crucial role in gallbladder inflammation. Receiver operating curve (ROC) and pathway analysis on NMR data were also carried out to validate the findings.
Results
Serum metabolites such as glutamine, low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), alanine, branch chained amino acids (BCAA), histidine and tyrosine were found to be depleted whereas formate, lactate, 1,2-propanediol were found to be elevated in CC. Metabolic pathways associated with metabolite alteration have also been reported.
Conclusions
NMR has been established for disease diagnosis along with identification of metabolic pattern recognition in biofluids. Gallstones cause inflammation of the gallbladder in the form of CC. Inflammation plays a major role in causation of gall bladder cancer and leads the way to malignancy. Metabolic analysis of CC may lead to early diagnosis of disease and its progression to gallbladder cancer.
Similar content being viewed by others
References
Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4:695–706.
Silk YN, Douglass HO, Nava HR, Driscoll DL, Tartarian G. Carcinoma of the gallbladder. The Roswell Park experience. Ann Surg. 1989;210:751–7.
Priya TP, Kapoor VK, Krishnani N, Agrawal V, Agrawal S. Role of E-cadherin gene in gall bladder cancer and its precursor lesions. Virchows Arch. 2010;456:507–14.
Maurer KJ, Carey MC, Fox JG. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology. 2009;136:425–40.
Singh VP, Rajesh S, Bihari C, Desai SN, Pargewar SS, Arora A. Xanthogranulomatous cholecystitis: what every radiologist should know. World J Radiol. 2016;8:183–91.
Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006;56:69–83.
van Erpecum KJ. Biliary lipids, water and cholesterol gallstones. Biol Cell. 2005;97:815–22.
Carey MC. Biliary lipids and gallstone formation. In: Csomós G, Thaler H, editors. Clinical hepatology: history present state outlook. Berlin: Springer; 1983. p. 52–69.
Behar J. Physiology and pathophysiology of the biliary tract: the gallbladder and sphincter of Oddi—A review. ISRN Physiol. 2013;2013:15.
Raffler J, Friedrich N, Arnold M, Kacprowski T, Rueedi R, Altmaier E, et al. Genome-wide association study with targeted and non-targeted nmr metabolomics identifies 15 novel loci of urinary human metabolic individuality. PLoS Genet. 2015;11:e1005487.
Zhang A, Sun H, Wang P, Han Y, Wang X. Recent and potential developments of biofluid analyses in metabolomics. J Proteom. 2012;75:1079–88.
Chen Z, Kim J. Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases. BMC Urol. 2016;16:016–0129.
Kork F, Gentsch A, Holthues J, Hellweg R, Jankowski V, Tepel M, et al. A biomarker for severity of Alzheimer’s disease: 1H-NMR resonances in cerebrospinal fluid correlate with performance in mini-mental-state-exam. Biomarkers. 2012;17:36–42.
Singh C, Rai R, Azim A, Sinha N, Ahmed A, Singh K, et al. Metabolic profiling of human lung injury by 1H high-resolution nuclear magnetic resonance spectroscopy of blood serum. Metabolomics. 2015;11:166–74.
Gupta A, Dwivedi M, Mahdi AA, Khetrapal CL, Bhandari M. Broad identification of bacterial type in urinary tract infection using 1H NMR spectroscopy. J Proteome Res. 2012;11:1844–54.
Nagana Gowda GA, Somashekar BS, Ijare OB, Sharma A, Kapoor VK, Khetrapal CL. One-step analysis of major bile components in human bile using 1H NMR spectroscopy. Lipids. 2006;41(6):577–89.
Viswan A, Sharma RK, Azim A, Sinha N. NMR-based metabolic snapshot from minibronchoalveolar lavage fluid: an approach to unfold human respiratory metabolomics. J Proteome Res. 2016;15(1):302–10.
Jayalakshmi K, Sonkar K, Behari A, Kapoor VK, Sinha N. Lipid profiling of cancerous and benign gallbladder tissues by 1H NMR spectroscopy. NMR Biomed. 2011;24:335–42.
Nagana Gowda GA, Raftery D. NMR spectroscopy-based metabolic profiling for detecting hepatobiliary diseases. Emerging trends in dietary components for preventing and combating disease. Am Chem Soc. 2012;1093:407–15.
Holmes E, Wijeyesekera A, Taylor-Robinson SD, Nicholson JK. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol. 2015;12:458–71.
Kimhofer T, Fye H, Taylor-Robinson S, Thursz M, Holmes E. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer. 2015;112:1141–56.
Murakami Y, Kubo S, Tamori A, Itami S, Kawamura E, Iwaisako K, et al. Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Sci Rep. 2015;5:16294.
Kapoor VK. Gall bladder cancer: what needs to be done in India? In: Gandhi V, Mehta K, Grover R, Pathak S, Aggarwal BB, editors. Multi-targeted approach to treatment of cancer. Berlin: Springer International Publishing; 2015. p. 179–87.
Schicho R, Shaykhutdinov R, Ngo J, Nazyrova A, Schneider C, Panaccione R, et al. Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res. 2012;11:3344–57.
Sonkar K, Behari A, Kapoor VK, Sinha N. 1H NMR metabolic profiling of human serum associated with benign and malignant gallstone diseases. Metabolomics. 2013;9:515–28.
Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, et al. Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009;104:1435–44.
Wasinski F, Gregnani MF, Ornellas FH, Bacurau AVN, et al. Lymphocyte glucose and glutamine metabolism as targets of the anti-inflammatory and immunomodulatory effects of exercise. Mediat Inflamm. 2014;2014:10.
Khovidhunkit W, Kim M-S, Memon RA, Shigenaga JK, Moser AH, Feingold KR, et al. Thematic review series: the pathogenesis of atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J Lipid Res. 2004;45:1169–96.
Watanabe M, Suliman ME, Qureshi AR, Garcia-Lopez E, Bárány P, Heimbürger O, et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr. 2008;87:1860–6.
Nagana Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. Metabolomics-based methods for early disease diagnostics: a review. Expert Rev Mol Diagn. 2008;8:617–33.
Acknowledgments
We acknowledge financial support from Department of Science and Technology (Grant Number EMR/2015/001758).
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: John Di Battista.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sharma, R.K., Mishra, K., Farooqui, A. et al. 1H nuclear magnetic resonance (NMR)-based serum metabolomics of human gallbladder inflammation. Inflamm. Res. 66, 97–105 (2017). https://doi.org/10.1007/s00011-016-0998-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-016-0998-y